These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 30413614
21. Susceptibility loci associations with prostate cancer risk in northern Chinese men. Wang NN, Xu Y, Yang K, Wei D, Zhang YG, Liu M, Shi XH, Liang SY, Sun L, Zhu XQ, Yang YG, Tang L, Zhao CX, Wang X, Chen X, Hui J, Zhang YH, Zhu L, Yang F, Zhang YR, Yang Z, Wang JY. Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082 [Abstract] [Full Text] [Related]
22. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P. Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283 [Abstract] [Full Text] [Related]
24. Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival. O'Mara TA, Nagle CM, Batra J, Kedda MA, Clements JA, Spurdle AB. Twin Res Hum Genet; 2011 Aug; 14(4):323-7. PubMed ID: 21787114 [Abstract] [Full Text] [Related]
25. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. Chen J, Cui X, Zhou H, Qin C, Cao Q, Ju X, Li P, Cai H, Zhu J, Meng X, Wang M, Zhang Z, Shao P, Li J, Yin C. BMC Cancer; 2013 Jul 24; 13():356. PubMed ID: 23883402 [Abstract] [Full Text] [Related]
29. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Lai J, Kedda MA, Hinze K, Smith RL, Yaxley J, Spurdle AB, Morris CP, Harris J, Clements JA. Carcinogenesis; 2007 May 24; 28(5):1032-9. PubMed ID: 17151093 [Abstract] [Full Text] [Related]
30. Association of six susceptibility Loci with prostate cancer in northern chinese men. Zhang YR, Xu Y, Yang K, Liu M, Wei D, Zhang YG, Shi XH, Wang JY, Yang F, Wang X, Liang SY, Zhao CX, Wang F, Chen X, Sun L, Zhu XQ, Zhu L, Yang YG, Tang L, Jiao HY, Huo ZH, Yang Z. Asian Pac J Cancer Prev; 2012 May 24; 13(12):6273-6. PubMed ID: 23464444 [Abstract] [Full Text] [Related]
31. Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis. Zhu W, Liu H, Wang X, Lu J, Zhang H, Wang S, Yang W. Biosci Rep; 2019 Mar 29; 39(3):. PubMed ID: 30765615 [Abstract] [Full Text] [Related]
32. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer. Zhu L, Wang J, Yue C, Yuan W, Zhang W, Shi L, Mi Y, Wu X, Zhang LF, Zuo L. J Cell Biochem; 2019 Oct 29; 120(10):18346-18356. PubMed ID: 31257659 [Abstract] [Full Text] [Related]